In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. The company expects to report first quarter GAAP shareholders’ net income of $9.61 per diluted share, including approximately $2.36 per diluted share of net unfavorable items. Excluding these items, adjusted shareholders’ net income was $11.97 per diluted share. “First quarter results reflect medical cost trends that developed in line with the Company’s expectations, including in its Medicare Advantage business. While cost trends in Medicare Advantage remain elevated, the Company’s first quarter experience was consistent with its expectations and pricing,” the company noted.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Morgan Stanley expects UnitedHealth shares to fall following guidance cut
- Nike initiated, GM downgraded: Wall Street’s top analyst calls
- Elevance Health price target raised to $428 from $405 at Morgan Stanley
- Elevance Health downgraded to Neutral from Outperform at Baird
- Elevance Health price target raised to $510 from $480 at Truist